Groundbreaking research demonstrates that retatrutide, a dual-action medication, may transform the management of excess weight . Distinct from many traditional weight loss solutions, retatrutide works as both a GLP-1 receiver and a GIP agonist, affecting several factors involved in appetite regulation and metabolic optimization. Preliminary clinic